Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 06/08/2026
In
Objective
To generate long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies, to include, but not limited to, pharmaceutical, biotechnology, medical device and healthcare services companies.
AIC sector
Management group
Company website
Launch date
15/06/2010
September
Domicile
United Kingdom
Fund manager
David Pinniger, James Douglas, Deane Donnigan, Gareth Powell
Dividend frequency
Semi-Annually
Wind-up provisions
The resolution for further continuation will be proposed at the 2026 AGM.
493.73
| Share type | Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Share | 460.53 | 453.73 | 442.50 | 435.96 | 1.50 | 7 | 0.50 | Feb, Aug | 0.9 (30/09/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 06/08/2026 | 28/08/2026 | 1.200 | No | 2026 |
| 05/02/2026 | 27/02/2026 | 1.000 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Polar Capital Global Healthcare | Share price total return | 34.4 | 36.1 | 63.3 | 141.7 |
| Healthcare & Biotechnology AIC sector | Share price total return | N/A | N/A | N/A | N/A |
Scroll
Share structure
20,074,256
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 499,915 | 8,142,969 | 116,310,714 | 322,721,831 |
| Polar Capital Glb Healthcare Ord Average | N/A | 354,042 | 459,726 | 255,925 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 2.21 | 35.98 | 471.44 | 1,162.49 |
| Polar Capital Glb Healthcare Ord Average | N/A | 1.56 | 1.86 | 0.92 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00B6832P16 | PCGH | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 30/06/2026
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 9.8 |
| Johnson & Johnson | 8.8 |
| UnitedHealth Group Inc | 6.9 |
| Roche Holding AG Ordinary Shares new | 5.8 |
| CVS Health Corp | 4.8 |
| Thermo Fisher Scientific Inc | 4.7 |
| Teva Pharmaceutical Industries Ltd ADR | 4.4 |
| Merck KGaA | 3.6 |
| Edwards Lifesciences Corp | 3.6 |
| AstraZeneca PLC | 3.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
